Matthias Karajannis is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 360 publications with 17,568 citations (h-index 59); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
Department Of Pediatrics, Box 234
New York, NY 100656007
Telephone
212-639-3171Registry record last updated 27 Apr 2017.
Clinical trials
- 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Sponsor: Pediatric Brain Tumor Consortium
- Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Sponsor: University of Alabama at Birmingham
- Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2012–2017 per NIH RePORTER. The latest:
- Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
New York University School of Medicine
FY2017$325,863R01CA164295 - Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
New York University School of Medicine
FY2016$1R01CA164295 - Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
New York University School of Medicine
FY2015$343,238R01CA164295
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
New England Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”